Low back pain (LBP) is a prevalent and often debilitating condition affecting millions worldwide. Traditional interventions for LBP frequently target 'dysfunctional' or atypical lumbo-pelvic kinematics, with the aim of correcting abnormal movement patterns. A recent exploratory study by Robert A. Laird and colleagues titled "Does movement matter in people with back pain? Investigating ‘atypical’ lumbo-pelvic kinematics in people with and without back pain using wireless movement sensors" sheds light on the relationship between these atypical kinematic parameters and LBP.

Key Findings from the Study

The study utilized wireless inertial motion units (IMU) and EMG sensors to measure various kinematic parameters during standing and sitting trunk, lumbar, and pelvic flexion in individuals with LBP and without LBP. Here are some notable findings:

1. Reduced Range of Motion (ROM): Individuals with LBP exhibited significantly reduced ROM during trunk, lumbar, and pelvic flexion compared to the non-LBP group. For instance, trunk flexion ROM was 111° in non-LBP individuals but only 93° in LBP individuals.

2. Greater Extensor Muscle Activation: The LBP group showed markedly higher extensor muscle activation during flexion, indicating a possible compensatory mechanism for instability or pain.

3. Delayed Pelvic Motion: There was a notable delay in pelvic motion at the onset of flexion in the LBP group, highlighting coordination difficulties.


4. Longer Movement Duration: Movement duration during flexion was significantly longer for those with LBP, suggesting slower and perhaps more cautious movement patterns.

These findings underscore the importance of targeting specific biomarkers, enabling providers to more effectively understand and treat LBP. The significant differences in movement patterns between those with and without LBP provide valuable insights for diagnosing and treating patients.

Advancements in Technology: FIGUR8's bioMotion Assessment Platform

In recent years, motion analysis technology has evolved tremendously, as shown by the introduction of wireless sensors. Traditional optical motion capture systems, while highly accurate, come with significant limitations:


High Costs: The setup and maintenance of optical systems are expensive, making them inaccessible for many practitioners.

Time and Expertise: Analyzing data from optical systems requires considerable time and specialized knowledge, often necessitating a dedicated team, further contributing to high costs and delays of proper treatment.


FIGUR8's bioMotion Assessment Platform addresses these challenges by offering a more accessible and user-friendly solution. Designed with the user in mind, their platform utilizes wearable sensors, such as IMUs and surface mechanomyography (sMMG), to capture detailed biomechanical data. The resulting insights provide a comprehensive analysis of movement patterns without expensive maintenance fees or specialized training.

FIGUR8’s technology is:

1. Cost-Effective: FIGUR8's platform is significantly more affordable than traditional optical systems, making advanced motion analysis accessible to a broader range of healthcare providers and settings.

2. Easily Integratable into Provider Workflows: The platform is designed for ease of use, allowing practitioners to efficiently capture and analyze movement data without extensive training. In as little as ten minutes, providers have access to a detailed report on their patients’ bioMotion data to help deliver the most effective care.


3. Portable: FIGUR8’s solution is portable, about the size of a laptop, and can be used in various settings, facilitating access to dynamic bioMotion analysis and near real-time feedback.


4. A Reliable Comparison: FIGUR8's platform reliably compares with traditional optical motion capture systems in terms of accuracy, providing trusted and high-quality data essential for effective treatment planning.

Implications for Physical Therapists and Patients

The integration of advanced motion capture technology like FIGUR8's bioMotion Assessment Platform into clinical practice has profound implications:


- Improved Diagnosis: Physical therapists now have access to tools that allow the easy collection of movement biomarkers to more accurately diagnose atypical movement patterns and tailor interventions for specific dysfunctions.

- Personalized Treatment: By understanding the precise nature of a patient's movements and compensatory patterns, providers can develop and deliver more personalized and effective treatment plans.

- Enhanced Patient Outcomes: Accurate and timely interventions based on reliable data can lead to better pain management and functional recovery for patients with LBP.

Conclusion

The study by Laird et al. emphasizes the significance of atypical lumbo-pelvic kinematics in understanding and treating low back pain. The adoption of modern technologies like FIGUR8’s bioMotion Assessment Platform can revolutionize how clinicians assess and manage LBP, making advanced motion analysis accessible and practical. By overcoming the limitations of traditional optical systems, these innovations hold the promise of delivering better patient outcomes while advancing the field of physical therapy.


To become FIGUR8-enabled connect with the team via email at info@figur8tech.com or reach out here today!


Understanding the Role of Movement in Low Back Pain

Understanding how muscles perform during movement has long posed a challenge in physical therapy and rehabilitation. Traditional tools like manual muscle testing inform about a single muscle’s force output while the person is in a static position. It does not provide information on muscle function during a dynamic task or on how it relates simultaneously to the function of other muscles for the coordination of a movement. Subtle deficits in functional strength, muscle balance or coordination can significantly influence movement, vulnerability to injury and recovery. Surface mechanomyography (sMMG) is revolutionizing understanding movement by offering a window into muscle function that’s objective, measurable, and captured in real time.

This non-invasive, sensor-based technology records how muscles behave during dynamic tasks—such as walking, squatting, or lifting—giving clinicians actionable insights into contraction magnitude, quality, and activation timing. These insights are invaluable for customizing care plans, adjusting interventions, tracking recovery, and ultimately improving outcomes. In this post, we will explore what sMMG is, how it works, and why it’s quickly becoming a powerful tool for personalized rehab, musculoskeletal health and performance screening.

Mechanomyography is a non-invasive technique that measures the mechanical components of muscles during a contraction (Scarborough et al 2024; Linderman et al 2023; Madeleine et al 2001; Ibitoye et al 2014). Mechanomyography can be used to identify and measure physical properties such as the timing of muscle activation, duration of a contraction, and the magnitude of a muscle contraction. When these metrics are captured during dynamic activities, they provide valuable information that clinicians can not see with their eyes or easily measure. Objective data that measures muscle function can better inform clinicians during a neuromuscular evaluation, when designing rehabilitations programs, and performing wellness screens.


There are numerous technologies that measure mechanical aspects of a muscle contraction, each with its own advantages and inherent limitations. Accelerometers, lasers, electrostatic microphones, retractable transducers, piezoelectric contact sensors, and electroactive polymer sensors are all examples of technology used for mechanomyography (Scarborough et al 2024, Ibitoye et al 2014).

FIGUR8, Inc invented the surface Mechanomyography (sMMG), that can be worn during a variety of dynamic activities while remaining user friendly across a variety of applications (Scarborough et al 2024, Linderman et al 2023).

The FIGUR8 bioMotion Assessment Platform (bMAP)

To gain quick, objective measurable insights on how an individual moves.sMMG data helps identify deficiencies, compensations, and asymmetries that aren't always visible, guiding the clinician to target specific areas with greater accuracy. With clearer information up front, clinicians can make faster, more informed decisions and tailor interventions that lead to better outcomes.

Common muscles evaluated by sMMG using the FIGUR8 bMAP:

To understand how sMMG works, it is best to start with understanding what the sMMG measures.

The FIGUR8 sMMG sensor captures the muscle contraction as depicted in the images above.

A message from the brain is sent to bend the elbow causing

neuronal activation of musculature (as seen with electromyography) which triggers a

muscle contraction. The muscle expands in size and movement occurs.

The sMMG sensor is placed across the belly of the muscle.

The sMMG sensor expands with the surface beneath it, as the bulk of the muscle enlarges during contraction as in the example above, the biceps as it bends the elbow.

A sMMG sensor is:
A flexible dielectric sensor that conforms to the surface beneath it and is secured either using adhesive tape or a strap. The sensor captures the mechanical properties of a muscle as the volume of the muscle mass changes during the contraction. The sMMG requires no skin prep, the sensor has very low issues with signal interference and there is no need for post signal processing.

The Magnitude of muscle output is the change in length of the sensor resulting from the expansion of the muscle belly during the contraction as it generates force needed to complete the activity (ie. bend the elbow).

The Rate of Contraction is calculated as the sensor is lengthened, telling us how quickly the contraction occurs.

Primary clinical biomechanics metrics: magnitude of sMMG signal representing muscle function and rate of contraction.

Secondary metric: timing of muscle activation and duration.

Primary biometrics provided from the sMMG sensor:

Muscle Function
      {{disc_list_start}}
Magnitude of muscle output
 Rate of Contraction{{disc_list_end}}

Muscle Function symmetry
       {{disc_list_start}}Comparison of right and left muscle function metrics{{disc_list_end}}

Muscle Balance
       {{disc_list_start}} Relationship of Magnitude of agonist and antagonist muscle function (ie. Quadriceps to Hamstrings muscle function){{disc_list_end}}

A sEMG sensor is :
An electrode that is secured with an adhesive directly to the skin above the muscle of interest to capture the electrical signal created during muscle activation (Illustration A.) (Basmajian and De Luca 1985).
The challenge of skin prep time, signal interference during data collection, post collection signal processing and relatively high cost limits application of sEMG in the majority of clinical settings.

Primary clinical biomechanics metric: timing of muscle activation and duration.

Secondary metric: magnitude of sEMG signal representing muscle function.

Clinical Synthesis of Lab-Grad Biomechanical Data

Below is an example of how data from a patient with chronic left knee pain may be synthesized and interpreted.

There is a shift from the range of expected standard Quadriceps to Hamstrings ratio to Hamstring dominance ratio on the left more than right. This finding suggests treatment focus on quad activation exercises and assessment of hip joint and hip musculature due to the compensation movement pattern. 

The illustration below represents the bilateral squat activity which was performed by the patient described above.

The Future of Personalized Care Using Biometric Motion Data
We're entering a new era of rehabilitation—one where care is tailored, responsive, and data-driven. With biomechanics platforms implementing sensors like the FIGUR8 surface mechanomyography (sMMG) for advanced motion capture, we are no longer guessing at how individuals move—we're measuring it. This objective insight empowers clinicians to make smarter decisions at every stage, from injury prevention and early intervention to progress tracking and performance optimization. It’s not just about treating symptoms anymore—it's about truly understanding how each individual moves, and using that knowledge to unlock better, faster, more personalized recovery.

By capturing objective dynamic joint motion and muscle function data, clinicians and care teams can make more informed decisions, whether enhancing injury prevention strategies, optimizing rehabilitation, or improving athletic performance.

Interested in learning more about sMMG technology and the future of musculoskeletal care? 
Connect with the team at FIGUR8, info@figur8tech.com


Scarborough DM, Linderman SE, Aspenleiter R, Berkson EM. Quantifying muscle contraction with a conductive electroactive polymer sensor: introduction to a novel surface mechanomyography device. Int Biomech. 2023 Dec;10(1):1-10. doi: 10.1080/23335432.2024.2319068.

Linderman SE, Scarborough DM, Aspenleiter R, Stein HS, Berkson EM. Assessing Quadriceps Muscle Contraction Using a Novel Surface Mechanomyography Sensor during Two Neuromuscular Control Screening Tasks. Sensors (Basel). 2023 Jun 29;23(13):6031. doi: 10.3390/s23136031.

Madeleine P, Ge HY, Jaskólska A, Farina D, Jaskólski A, Arendt-Nielsen L. Spectral moments of mechanomyographic signals recorded with accelerometer and microphone during sustained fatiguing contractions. Med Biol Eng Comput. 2006 Apr;44(4):290-7. doi: 10.1007/s11517-006-0036-2.

Ibitoye MO, Hamzaid NA, Zuniga JM, Wahab AKA. Mechanomyography and muscle function assessment: A review of current state and prospects. Clinical Biomechanics, 2014;29(6), 691 - 704. doi.org/10.1016/j.clinbiomech.2014.04.003

Basmajian, J.V.; De Luca, C.J. Muscles Alive: Their Functions Revealed by Electromyography, 5th ed.; Williams & Wilkins: Baltimore, MD, USA, 1985; ISBN 068300414X.

Delsys. Technical Note 101: EMG Sensor Placement. Available online: https://www.delsys.com/downloads/TECHNICALNOTE/101-emg-sensor-placement.pdf (accessed on 30 December 2020).

Discover how surface mechanomyography (sMMG) offers real-time muscle insights to guide rehabilitation, improve musculoskeletal health and enhance performance.

Introduction to Surface Mechanomyography (sMMG)

Image: Noah Lyles claims Olympic gold in heart-stopping finish - by five thousandths of a second. https://www.nbcolympics.com/

In the world of elite sports, the difference between success and failure often lies in the smallest details. For Olympians, tiny improvements in movement can mean the difference between breaking a world record and falling just short. The impact of these small adjustments extends far beyond the competition; they play a crucial role in recovery, where every minor improvement can lead to significant gains.

Is 35 seconds a little time or a lot of time?

While 35 seconds may seem like a small gap, it’s a testament to the power of incremental progress. 

Consider the quest to break the 2-hour barrier in the marathon. Nike was determined to make waves and led the quest, documented in the documentary “Breaking2”, and the continued efforts to achieve this goal in an official marathon. Currently, the record is 2:00:35 set by Kelvin Kiptum of Kenya at the 2023 Chicago Marathon on October 8, 2023 just 35 seconds from the goal.


A marathon covers 26.2 miles, or approximately 54,608 steps for a runner with a 27-inch stride. To cut 35 seconds off that time, a runner would need to lengthen each step by just 0.052 inches—a measurement as thin as a credit card.

This small of an adjustment may seem insignificant, but it highlights a fundamental truth in sports science: small changes, when consistently applied, can lead to massive change and improvements. 

The same principle applies to recovery. Just as an Olympian makes small tweaks to enhance performance, each of us can make minor adjustments that have a profound impact on our recovery time and lasting health.

Recovery: The Key to Sustained Performance

Injury prevention and recovery are as critical to athletes as their performance on the field. The quicker an athlete can recover, the more effectively they can train, compete, and perform at their peak. 

This is where solutions like FIGUR8 come into play. By providing highly accurate data on movement, FIGUR8 helps athletes and individuals make informed decisions that lead to better outcomes.

Imagine an Olympian fine-tuning their stride to reduce strain on a specific area of the body. Over time, these tiny adjustments can prevent injuries, shorten recovery periods, and allow for more intensive training. Similarly, in everyday life, small improvements in how we move—whether it’s adjusting our posture or refining our walking technique—can have a significant impact on our overall health and recovery.

Data-Driven Decisions for Better Performance and Recovery

The real power of recovery biometric solutions like FIGUR8 lies in the ability to provide precise data that informs the user on what adjustments to make. When we have access to accurate information about our movements, we can make better decisions regarding our personal care. For example, identifying a slight imbalance in how we distribute our weight when walking could lead to a small correction that prevents long-term injury and speeds up recovery after exercise.


In this way, every small decision we make, guided by accurate data, contributes to a healthier, more resilient body. Just as an Olympian’s tiny adjustments lead to world-record performances, our small, data-driven adjustments can lead to better overall health and the ability to meet our own record-breaking goals.

Whether it’s an Olympian shaving milliseconds off their race time or someone recovering from an injury, the principle is the same: small changes lead to big results. These tiny adjustments, when made consistently and informed by accurate data, have a compounding effect. 

As we continue to push the limits of what’s possible, whether in sports or everyday life, the importance of small, data-driven decisions continues to be at the forefront for personal care.. Solutions like FIGUR8 are spearheading this movement, empowering us to make the right choices that lead to better outcomes.

How Tiny Adjustments Lead to Faster Recovery

In the world of workers’ compensation, staying current on best practices is key — and that’s where Continuing Education Units (CEUs) come in. CEUs are accredited learning opportunities that help professionals maintain their licenses, deepen their expertise, and stay up to date on evolving industry standards. For workers' comp adjusters, CEU courses are a valuable way to build skills, expand knowledge, and gain insights into new tools and strategies shaping claims management — like the growing role of objective data in musculoskeletal (MSK) recovery.

FIGUR8 team member Jeff Vari, PT, DPT, MBA, has created a profound look into the evolution of biomechanical data and AI-driven insights in his CEU course “Using Objective Data to Guide MSK Recovery” that supports claims adjusters. The CEU course focuses specifically on how novel technology is transforming and simplifying MSK claims management - allowing for better outcomes for injured workers and ultimately leading to faster claims resolution. 

Below you will find a brief outline of the content that is covered in the CEU courses that take place periodically throughout the United States.

As objective data begins to pave the way in MSK treatments, it’s imperative to understand what objective data is and its application to MSK recovery, the importance of current technologies that support the use of objective data in claims management, and its benefit to adjusters.

Using Objective Data to Guide MSK Recovery

Many adjusters would agree that musculoskeletal (MSK) injuries tend to be one of the more challenging case types while handling workers’ compensation claims. MSK injuries are complex, often challenging to heal, and have diverse outcomes based on a large variety of factors. Due to this variety, recovery for one injured worker can look very different from recovery for another. Adjusters are often challenged day-in and day-out  to accurately evaluate progress and make correct verdicts on paramount decisions during recovery, including a claimant's compensability and whether or not medical necessity is evident.

As technology and healthcare continue to integrate, partners like FIGUR8 are raising the standard of care in MSK health and increasing clarity with the support of objective insights into individual recovery.

1. What is Objective Data and How does it Support Injury Recovery?

Objective data refers to measurable, quantifiable information that provides insight into a person’s physical state and functional capabilities. Subjective data, such as asking a patient to rate their pain on a scale of one to ten, can be beneficial, but is subjective and does not provide reliable information on physical health. When making important decisions in claims management, having objective data allows adjusters to utilize consistent, reliable, and reproducible data which allows for greater accuracy in claim decisions while lightening the load of sifting through case updates.

Types of Objective Data in MSK Recovery
In the context of musculoskeletal care, objective data can include:

Joint Range of Motion (ROM): How far a joint can move in different directions.

Muscle Activation: Measured through technologies like surface mechanomyography (sMMG).

Functional Performance: How well a patient performs functional movement patterns such as walking, bending, or squatting.

Positional Endurance: Measured using precise sensors that allow better understanding in tolerance related to functional and work related tasks.

Movement Quality: The ability to look at more than just quantity of motion and gain greater insight into function and sustainability of a particular movement / task.

Being able to access objective data removes guesswork and helps guide decision making. Instead of over relying on subjective patient feedback, adjusters and clinicians can now visualize recovery progress with precision.

2. Why Use Objective Data in Workers’ Compensation Claims?

For workers’ compensation claims adjusters, objective data provides several strategic advantages:

Improved Decision-Making
One of the biggest challenges in MSK claims management is determining whether a 
worker is genuinely progressing or has plateaued in their recovery. Objective data allows
adjusters to:
  a. Track functional improvements over time with consistent metrics.
  b. Compare current function against baseline data and health reference ranges.
  c. Validate whether a treatment plan is effective or if adjustments are needed.
For example, joint range of motion and muscle strength measurements can 
reveal whether an injured worker’s physical capacity aligns with their job 
requirements.


Improved Claim Communication
Subjective data often leads to misalignment between adjusters, providers, and injured 
workers. Objective data reduces disputes by providing clear, measurable evidence of 
recovery progress, whether it be positive or negative.
    a. If a worker reports ongoing pain but objective data shows improved joint function 
and muscle strength, an adjuster can objectively evaluate whether additional 
and/or alternative treatment is necessary.
    b. If the data indicates poor recovery despite consistent therapy, it may prompt a 
reassessment of the treatment plan or consideration of alternative care options.
    c. This helps prevent unnecessary treatments, overutilization of care, and 
protracted claims.


Faster Claims Resolution
Accurate data leads to more informed and timely decisions. When adjusters have clear 
evidence of functional recovery, they can:
    a. Confirm treatment is medically necessary for injured workers.
    b. Close claims more quickly when recovery is complete.
    c. Justify medical necessity with precise clinical data.
    d. Reduce time spent reviewing notes that provide subjective data and limited value.
    e. Understand an injured worker's objective status as it relates to their injury and work related recovery

Better Outcomes for Injured Workers
Objective data enhances not only claims insight but also patient outcomes. When 
treatment plans are guided by objective data on joint function and muscle performance, 
care becomes more effective through individualization.
    a. Providers can modify rehab protocols based on response to care.
    b. Workers feel more confident in their recovery when they see measurable improvements.
    c. Early identification of recovery setbacks allows for faster clinical intervention.
By using data to align clinical goals with functional recovery, adjusters and providers can ensure more successful return-to-work outcomes, leaving all involved parties happy and healthier.

The use of objective data in MSK claims management has expanded significantly with the rise 
of AI and advanced biomechanics tools. Several leading technologies are shaping the 
landscape.



How Adjusters Can Leverage Objective Data
Integrating objective data into the claims process doesn’t require a complete overhaul of 
existing systems.
Adjusters can start by:
  1. Partnering with clinics and providers who use objective tools.
  2. Requesting functional progress reports that include objective metrics.
  3. Using AI-generated data to identify intervention progress and triage appropriately.
By aligning clinical insights with claims decisions, adjusters can resolve cases faster, reduce costs, and improve worker satisfaction

Objective data is transforming MSK recovery and claims management. By replacing subjective assessments with measurable insights on joint motion, muscle strength, and functional endurance, adjusters can make better decisions, reduce disputes, and accelerate return-to-work outcomes.
AI and objective tools provide the framework for a more precise, data-driven approach to MSK care—allowing claims adjusters to work smarter, not harder. The future of workers’ compensation lies in using data to bring clarity and confidence to every claim.

{{center_align}}If you are interested in attending a CEU course and would like to find out when the next one is scheduled, please reach out to Jeff directly at jeff.vari@figur8tech.com{{center_align}}

FIGUR8 is at the forefront of this shift toward data-driven MSK care. 
The FIGUR8 bioMotion Assessment Platform (bMAP) captures high-quality biomechanics data using advanced sensors and AI. This provides clinicians and adjusters with detailed insights into joint motion, muscle function, and recovery progress. By integrating FIGUR8’s objective data into the claims process,adjusters can reduce disputes, accelerate resolution times, and improve return-to-work outcomes. FIGUR8’s technology empowers both clinicians and adjusters to make smarter, more confident decisions.

For more insights on how to integrate objective data into your claims process, reach out to the team at FIGUR8 at info@figur8tech.com

Why MSK CEU Education Is a Must-Have for Today’s Adjusters

At FIGUR8, our vision is shaped by the brilliant minds of our Board Members, Clinical, and Business Advisors. In our new "Degrees of Freedom" blog series, we sit down with these industry leaders to uncover the personal motivations, technological innovations, strategic approaches, and future visions that guide their work and why they are excited about FIGUR8. Through eight carefully crafted questions, we'll delve into what drives their passion for transforming musculoskeletal care, how they envision the future of health tech, and the innovative strategies they employ to lead us toward it. 

Join us on this journey to learn more about the experts shaping the future of FIGUR8 and the broader healthcare landscape.

Introducing Chris Brigham, MD: A Pioneer in Workers' Compensation and Musculoskeletal Health

Dr. Chris Brigham is a seasoned occupational medicine physician with over 30 years of experience addressing the complexities of workers' compensation and personal injury. Throughout his career, Dr. Brigham has been dedicated to bringing clarity to musculoskeletal issues, focusing on evidence-based medicine and innovative technologies like those pioneered by FIGUR8. A prolific writer, Dr. Brigham has authored numerous books and over 300 publications. He has also served as editor for the American Medical Association, including their pivotal AMA Guides to the Evaluation of Permanent Impairment.

Personal Journey and Connection: Can you share a bit about your personal journey and what initially drew you to become a Clinical Advisor at FIGUR8?

My journey to becoming an Advisor at FIGUR8 was a natural progression of my career in occupational medicine. With decades of experience in impairment assessment, including serving as the Editor of several AMA Guides publications,  I've always been passionate about improving patient outcomes. When I learned about FIGUR8's innovative approach to musculoskeletal care, I was immediately intrigued.

Their use of advanced sensor technology to objectively measure movement resonated with my commitment to evidence-based medicine. Joining FIGUR8 as an Advisor offered an exciting opportunity to contribute to a paradigm shift in how we diagnose and treat musculoskeletal conditions.

Vision and Mission Alignment: How does FIGUR8's mission to revolutionize musculoskeletal care resonate with your own professional values and goals?

FIGUR8's mission aligns perfectly with my professional values, focusing on integrity, excellence, and innovation. Throughout my career, I've advocated for evidence-based medicine and objective, data-driven approaches to patient care. FIGUR8's technology provides precisely that - a quantitative method to assess musculoskeletal function. This aligns with my goal of enhancing the accuracy of evaluations and improving treatment outcomes.

Moreover, their focus on non-invasive, patient-friendly solutions resonates with my belief in patient-centered care. FIGUR8's vision of revolutionizing musculoskeletal care through technology is a natural extension of my lifelong commitment to advancing occupational medicine and rehabilitation.

Technological Innovation: In your opinion, what makes FIGUR8 stand out in the healthcare technology landscape?

What sets FIGUR8 apart is its unique combination of wearable sensors and advanced analytics. Unlike traditional assessment methods that rely heavily on subjective observations, FIGUR8's technology provides objective, quantifiable data on movement patterns. This level of precision in measuring musculoskeletal function is unprecedented.

Furthermore, their use of AI and machine learning to analyze this data offers insights that were previously unattainable. This innovative approach not only enhances diagnostic accuracy but also enables personalized treatment plans and more effective monitoring of patient progress. It's a game-changer in the field of musculoskeletal care.

Impact on Patient Care: Can you discuss your thoughts on how FIGUR8's technology has transformed patient outcomes and improved recovery times?

FIGUR8's technology has had a profound impact on patient outcomes. By providing precise, objective measurements of musculoskeletal function, it enables more accurate diagnoses and tailored treatment plans. This leads to faster recovery times and improved functional outcomes.

Patients benefit from more targeted interventions, reducing the need for unnecessary treatments. The technology also allows for better tracking of progress, which can be motivating for patients and helps in fine-tuning treatment strategies.

Additionally, the non-invasive nature of the assessment means patients can be evaluated more frequently without discomfort, leading to better overall care management.

Challenges and Solutions: What are some of the biggest challenges FIGUR8 has faced in its development and implementation, and how have these been overcome?

One of the biggest challenges FIGUR8 faced was gaining acceptance in a field traditionally reliant on subjective assessments. Overcoming this required extensive validation studies and education of healthcare providers. Another challenge was integrating the technology seamlessly into existing clinical workflows. FIGUR8 addressed this through user-friendly interfaces and comprehensive training programs.

Data privacy and security were also critical concerns, which were met with robust encryption and compliance measures.

Lastly, scaling the technology while maintaining accuracy and reliability required significant R&D efforts. These challenges were overcome through persistence, continuous innovation, and close collaboration with healthcare providers and technology experts.

Future of Musculoskeletal Care: Where do you see the future of musculoskeletal care heading, and how do you envision FIGUR8 playing a role in that future?

The future of musculoskeletal care is undoubtedly data-driven and personalized, with a firm foundation in evidence-based medicine and innovative technologies. I envision a shift towards continuous monitoring and preventive care, rather than just treatment of existing conditions. FIGUR8 is well-positioned to lead this transformation.

The technology can enable early detection of potential issues, allowing for preventive interventions. I also see potential for integration with telemedicine platforms, making expert care more accessible. As AI and machine learning advance, FIGUR8's predictive capabilities will likely improve, further enhancing treatment outcomes.

The company's commitment to innovation suggests they'll continue to be at the forefront of these developments, shaping the future of musculoskeletal care.

Collaborations and Partnerships: How important are strategic partnerships and collaborations for FIGUR8, and can you highlight any key partnerships that have been particularly impactful?

Strategic partnerships have been crucial to FIGUR8's success. Collaborations with leading research institutions have been particularly impactful, providing validation for the technology and driving further innovation. Partnerships with healthcare providers and clinics have been essential for real-world implementation and refinement of the technology. Additionally, collaborations with sports teams and organizations have demonstrated the technology's versatility beyond clinical settings. These partnerships have not only enhanced FIGUR8's credibility but also expanded its reach and application.

Moving forward, I believe partnerships with payers and large healthcare systems will be key to wider adoption and integration of FIGUR8's technology.

Advice for Innovators: What advice would you give to other innovators and startups in the health tech space who are looking to make a significant impact on patient care and outcomes?

My advice to innovators in health tech is to stay focused on solving real clinical problems. Engage closely with healthcare providers and patients to understand their needs and pain points. Don't just innovate for the sake of technology – ensure your solutions deliver tangible improvements in patient care and outcomes. Prioritize rigorous scientific validation of your technology; credibility is crucial in healthcare. Be prepared for a long journey – healthcare is a complex field with many stakeholders and regulatory considerations. Build a diverse team that combines clinical, technical, and business expertise.

Lastly, be adaptable and resilient. The healthcare landscape is constantly evolving, and successful innovators need to be able to pivot and persevere in the face of challenges.

Dr. Chris Brigham's decades of dedication to improving clarity and advancing evidence-based practices in workers' compensation and musculoskeletal health shine through in his collaboration with FIGUR8. His contributions not only enhance our understanding of these complex issues but also help pave the way for innovative solutions that bridge gaps in care. We’re grateful for his insights and expertise as we continue to drive change and improve outcomes in MSK health. 

Stay tuned for more thought leadership from experts like Dr. Brigham via The Faces of FIGUR8. 

8 Questions Answered by the Minds Behind the Movement, Featuring Dr. Chris Brigham

After attending the 50th Annual APTA Combined Sections Meeting (CSM), one thing is clear—change is here. The conversations, the energy, and the mindset of this year’s attendees were different. There was a sense of urgency, a collective recognition that physical therapy must evolve. The status quo is no longer enough, and the industry is finally pushing itself toward meaningful innovation.

A New Era for Recruiting in Physical Therapy

It’s no secret that staffing shortages continue to be one of the biggest challenges in the physical therapy industry. CSM remains the premier event where students and current therapists explore career opportunities, but this year felt different. The days of organizations showing up with nothing more than a logoed pen and a goodie bag are over. Talent is at a premium, and recruiters know they need to bring more to the table—stronger incentives, clearer career paths, and a real commitment to clinician growth and success.


What stood out to me most was the energy of the students. There’s a buzz about them, an excitement that makes me optimistic about the future of physical therapy. They aren’t just looking for jobs; they’re looking for purpose, for the right fit. If organizations recognize and harness that energy, the industry will be better for it.

Every health system, physical therapy organization, and clinic is looking for an edge—something to help them navigate declining reimbursements, interoperability challenges, and the fight for differentiation in an increasingly saturated market. Partnerships have always been part of the equation, but this year, I saw a shift. Organizations are no longer just looking for an additional revenue stream; they are demanding real clinical value, operational efficiencies, and better experiences for both therapists and patients.

True partnerships must be a win-win. The organizations I spoke with aren’t just adopting new tools—they are holding their partners accountable for delivering measurable outcomes. The days of empty promises and unproven solutions are fading. If a partnership doesn’t drive tangible results, it won’t last.

Striving for excellence is admirable, but what the industry really needs is continuous improvement. For too long, physical therapy has been resistant to change, stuck in the mindset of “this is how we’ve always done it.” But at CSM, there was a clear acknowledgement that this approach is no longer acceptable.

From upgraded EMRs to new technologies, from improved data collection to more outcome-driven care, the industry is actively pushing itself forward. And while we still have a long way to go, this collective effort to “level up” is what will finally move physical therapy closer to true excellence.

CSM 2025 wasn’t just another conference. It was a sign that the industry is evolving. That clinicians, organizations, and innovators alike are ready to move beyond tradition and embrace what’s next. And for the first time in a long time, I left feeling like real progress is on the horizon.

Because movement is life. And physical therapy is finally moving forward.

Interested in connecting with Matt? Reach out at matt.byrne@figur8tech.com 

3 Key Takeaways from APTA CSM 2025: Mission to Excellence, Expanding Horizons in Physical Therapy

As the excitement builds for CES 2025, the global stage for innovation and technology, we are thrilled to highlight a conversation with Nan-Wei Gong, the visionary founder and CEO of FIGUR8 and René Quashie Vice President, Digital Health at the Consumer Technology Association. 

CES is known for showcasing groundbreaking advancements, and FIGUR8 is no exception. In this exclusive interview, Nan-Wei shares how FIGUR8’s bioMotion Assessment Platform (bMAP) is redefining musculoskeletal (MSK) care by creating a common language across providers, patients, and payers. With technology designed to empower clinicians and enhance recovery outcomes, FIGUR8 is paving the way for a future of precision in MSK health.

Please describe what your company does and what role it plays in the healthcare system?

FIGUR8 is a technology company that’s redefining musculoskeletal (MSK) health through precision measurement and data-driven insights. We developed the bioMotion Assessment Platform (bMAP), which captures objective biomechanical data on joint motion and muscle function in real-time and is a cornerstone in the foundational dataset that feeds into the generative AI tools that our team is able to provide FIGUR8-enabled clinicians. This dataset helps clinicians make more accurate diagnoses, create tailored treatment plans, and monitor patient progress with clear, quantifiable metrics. In a healthcare system where MSK disorders are one of the top cost drivers, FIGUR8 aims to bring clarity and precision to an area that has long relied on subjective assessments and patient reported outcome. Our mission is to create a common language for MSK health, uniting providers, patients, and payers around a shared standard of care.

In the last two years, what has been the environment like for emerging companies like yours?

The environment has been both exciting and challenging for emerging companies like FIGUR8. The healthcare industry is increasingly recognizing the value of data-driven insights and precision tools, especially in areas like MSK care which drive huge costs both financially and physically across all populations. This shift of recognition when it comes to the value of technology integrated care has created an openness to new and changing technologies, but it has also made the landscape more competitive as many companies seek to capitalize on digital health innovation. While there’s great opportunity, it requires resilience and adaptability to stand out, build trust, and make a lasting impact in an industry undergoing rapid transformation.

What are some of the biggest challenges you have faced as a founder?

One of the biggest challenges I have faced as a founder specifically at FIGUR8 is balancing innovation with market readiness. As an engineer out of the MIT Media lab, pushing the boundaries of what is possible using technology is part of my ethos. Healthcare is a complex landscape and being thoughtful about bringing in technology means ensuring we have decades, not months or years, of research to support the process changes we are forcing to raise the standard of care. FIGUR8 has a unique, groundbreaking technology, and bringing it to a traditional field like MSK care means navigating a complex landscape of healthcare providers, insurance payers, and regulatory requirements. 

Another fun challenge founding FIGUR8 has been the constant focus on building a team that aligns with both our technical needs and our mission to transform the standard of care in MSK health. Scaling the team and company culture while maintaining our focus on innovation and quality has been challenging but rewarding. It is important to maintain clinical rigor and consistently contribute a stream of validation via research which means having the right team guide and safeguard our quality processes. 

Lastly, educating the market on the importance of objective MSK data and the potential impact of FIGUR8 has required persistence and patience. Artificial Intelligence is exciting, and you see different companies popping up all the time promising to deliver impact. The reality is, FIGUR8 has a foundational dataset of objective MSK health biomarkers that are validated to be comparable to the gold standard in biomechanics data capture. Because of this, our team has the ability to set a new standard of care and reporting in managing joint and muscle health in an unparalleled way. 

What are some things you wished you had known when you started your company?

It is hard to say there is much I “wish I had known” since part of being an entrepreneur is embracing what you do not know and enjoying the challenge. 

One of the most valuable lessons I’ve learned is the importance of being truly human-centered and provider-focused in designing technology. Early on, we were so focused on building an innovative product that it could sometimes be easy to overlook how critical it is to prioritize the day-to-day experiences of healthcare providers who would be using the devices. 

The technology was born in a lab that has focused decades of research on wearable and the focus was always data quality. I wish I had known just how essential it is to deeply understand their workflows, pain points, and the nuances of patient care from their perspective. That information has come and empowering the right team members to push for human-centered design has been a huge part of our success. Technology in healthcare can’t just be innovative; it has to fit seamlessly into the provider’s workflow and genuinely enhance their ability to deliver care. By designing with the provider's experience in mind, we build trust, improve adoption, and ultimately create a solution that resonates with both providers and patients. That human-centered approach has been transformative in how FIGUR8 develops technology today.

From your perspective, what are the biggest challenges facing the healthcare system when it comes to technology adoption and innovation?

One of the biggest challenges in healthcare is the fragmented nature of the system, which can make technology and process integration complex. Different stakeholders—providers, payers, regulators—often operate in silos, which can slow down technology adoption. The needs are also different particularly when it comes to the value of the technology. 

For example, the type of data and level of detail needed in FIGUR8 reporting is different for a physical therapist, a case manager in insurance and a patient recovering from injury. They all want to understand recovery, but their needs are different. The way the information captured during a recovery assessment is shared has to be personalized to the individual stakeholders level of need and understanding. 

Additionally, when it comes to adoption of anything different or new in healthcare there’s a general resistance to change due to the perception that new technologies might disrupt established workflows or add time to patient interactions. In healthcare, any technology needs to show clear, measurable benefits not just for patient outcomes but also in terms of cost savings, efficiency, and quality of care to justify any workflow disruption. Overcoming these hurdles requires consistent education, strong data to demonstrate value, and often, strategic partnerships with established players who can advocate for the technology which luckily has been a relatively smooth process of overcoming since FIGUR8 entered the market.

As you look forward 3-5 years, how do you anticipate technology will have changed healthcare—if at all?

In the next 3-5 years, I anticipate that technology will drive healthcare to become more personalized, predictive, and preventive. Data-driven solutions will empower providers to make faster, more accurate diagnoses and allow patients to take a more active role in their own health. I see the use of wearable and remote monitoring devices becoming the norm, providing real-time insights that will enable early intervention and improve outcomes. I also believe that we’ll see a shift towards value-based care models, where technology like FIGUR8’s objective MSK assessments can help demonstrate outcomes, reduce costs, and improve quality of life for patients. Technology will not only make healthcare more efficient but also more human-centered by creating a common language across the care team, enhancing collaboration, and ultimately elevating the standard of care.

As CES 2025 approaches, the spotlight is on innovators like Nan-Wei Gong, who are transforming healthcare through cutting-edge technology. Nan-Wei will be taking the stage at CES to discuss how FIGUR8 is setting a new standard in musculoskeletal care, merging data-driven insights with clinical expertise to elevate recovery outcomes. Stay tuned for her presentation at CES and discover how FIGUR8 is shaping the future of healthcare. Don’t miss this opportunity to learn from one of the most forward-thinking leaders in the industry!

Interested in learning more about FIGUR8 and raising the standard of care in musculoskeletal health? Reach out to the team at info@FIGUR8tech.com!

Reflections from Med Tech Founders with Nan-Wei Gong, Founder and CEO of FIGUR8

This case study of a kennel assistant with a back injury illustrates how FIGUR8 enhances the experience across the board—for providers, patients, and payers alike.

In the complex world of workers' compensation and musculoskeletal (MSK) care, achieving optimal recovery outcomes means addressing not just the physical injury but the psychological, emotional, and financial aspects of healing as well. FIGUR8’s innovative bioMotion Assessment Platform (bMAP) is transforming the way providers, patients, and payers navigate this journey. Through objective, data-driven insights, FIGUR8 supports more accurate, personalized care that accelerates recovery, reduces costs, and empowers all stakeholders involved.

The patient, a kennel assistant, suffered a back injury while lifting a heavy dog at work. Initially, she took a few days off work before returning to light duty. Despite visiting her primary care physician (PCP) and receiving a physical therapy (PT) referral, no imaging was performed. Her pain persisted, prompting her to begin a structured PT regimen to support and expedite her full return-to-work and recovery.

For the physical therapist managing this case, FIGUR8 was a powerful tool for guiding treatment and tracking progress. The platform provided objective, quantitative data on the patient’s MSK function over time, helping the provider make informed decisions about her readiness for discharge.

With FIGUR8’s data, the provider could clearly see the patient’s improvements in functional movement and muscle activation. This allowed the therapist to adjust the treatment plan with confidence and avoid unnecessary sessions. As a result, the provider was able to bring the patient to a safe and effective discharge at just 56 days of care—significantly lower than the ODG average duration of 85 days. For the clinician, FIGUR8 streamlined decision-making, offering an evidence-based approach that removed much of the guesswork from traditional MSK assessments.

Improved Patient Experience: Motivation Through Measurable Progress

One unique aspect of this patient’s case was her high psychological influence on her perception of disability. In such cases, having a visual, objective demonstration of progress is critical for motivation and reassurance. FIGUR8 provided exactly that—a clear, tangible record of her progress over three assessment sessions.

By the time of her final assessment, FIGUR8’s data showed the patient’s marked improvement. For her, seeing this progress in quantifiable terms was not only encouraging but also empowering. Knowing that she was nearing discharge and had successfully improved from her initial injury gave her confidence in her recovery journey. At her last FIGUR8 assessment, the patient expressed excitement at seeing her functional scores, which motivated her to stay engaged in her rehabilitation. This kind of positive patient experience is key to improving adherence and achieving successful outcomes.

Better Insights for Payers and State Funds: Cost Savings and Accelerated Recovery

For payers and state funds, FIGUR8’s impact on cost and efficiency is undeniable. This case demonstrated a significant reduction in both care duration and cost. With FIGUR8-enabled care, the total cost came to $20,496.72—a 32.35% savings compared to the ODG average of $30,296.00. This translated to a value of nearly $9,800 saved in the care of this one patient.

By reducing the total days under care and offering a clear path to recovery, FIGUR8 supports payers and state funds in optimizing claims costs. The objective data provided by the platform helps ensure that resources are used effectively and that patients receive the right amount of care for their specific needs. For workers' compensation programs, these outcomes represent a valuable opportunity to allocate funds more efficiently, manage claims costs, and support faster return-to-work times for injured workers.

This case study exemplifies how FIGUR8 is transforming the landscape of musculoskeletal care. By providing accurate, objective data, FIGUR8 improves the provider experience, making it easier to deliver precise, personalized care. Patients benefit from increased motivation and understanding of their recovery journey, while payers and state funds experience substantial cost savings and efficiency gains.

In this case, FIGUR8 helped reduce recovery time from 85 days to just 56 and saved almost $10,000 in care costs. Beyond the numbers, FIGUR8 fosters a collaborative, transparent environment where providers, patients, and payers can all play an active role in the recovery process. This common language of data and insights sets a new standard for musculoskeletal health, offering a path to better outcomes and more sustainable care for all involved. 

As FIGUR8 continues to empower more providers, patients, and payers, we look forward to a future where musculoskeletal care is precise, measurable, and truly patient-centered.

Interested in figuring out how to enable FIGUR8? Connect with the team by clicking here, or email us at info@figur8tech.com.

Case Study: Injured Kennel Worker in Maine Recovers from Back Injury 35% Faster With FIGUR8

In the complex world of musculoskeletal (MSK) care, clear communication and collaboration among healthcare professionals can be challenging, particularly within the realm of complex cases in workers' compensation. Fragmented care and varied approaches across the care continuum often result in prolonged recovery times and increased costs. However, advancements in technology are enabling a transformative shift in MSK care, paving the way for a common language that fosters shared decision-making, improved patient outcomes, and a streamlined return-to-work process.

At the recent NWCD conference in Las Vegas, a panel on "Creating a Common Language in Musculoskeletal Care" was shared where leaders in physical therapy, orthopedic surgery, and workers' compensation came together to discuss this shift. 

The panel included Rob Pace, COO of the Physical Rehabilitation Network, Dr. Benedict Nwachukwu, orthopedic surgeon and CEO of Best in Class MD, and Lisa Fitzpatrick, CEO of XcelABLE and an occupational therapist. This group of experts explored how integrating digital tools and data-driven approaches can create a unified approach in MSK care that benefits patients, healthcare providers, and payers alike.

Panelists discuss using technology to improve communication and patient care at the National Workers' Compensation and Disability Conference (from left to right Josh Williams with FIGUR8, Dr. Benedict Nwachukwu with Best In Class MD, Dr. Lisa Fitzpatrick with XcelABLE and Rob Pace with PRN.

One of the key challenges in workers' compensation and MSK care is the fragmented nature of communication among care teams. Information collected from an injured individual is often subjective and relies heavily on a provider's expertise to understand. Without a shared framework or language to guide communication across care teams, patients are often faced with delays in receiving effective treatment, which can hinder recovery and further delay their return to work. 

By establishing a common language using objective data to understand and monitor physical recovery, stakeholders across the MSK care spectrum—from physical therapists to orthopedic surgeons to case managers—can make more informed and cohesive decisions.

The Role of Technology in Breaking Down Silos

Advancements in in-clinic assessment technology are proving to be invaluable in standardizing MSK care. Tools like the bioMotion Assessment Platform by FIGUR8 enable physical therapists and other care MSK care providers to perform precise physical exams at any point of care.

With FIGUR8 tools enabled, providers now have best-in-class objective, data-driven insights that reduce clinical guesswork and enhance diagnostic accuracy which in turn raises the standard of care and lowers recovery time. Injured workers have been documented to recover over 50% faster with the support of bioMotion technology, as shown in the case study linked here with FIGUR8 enabled provider Team Rehab.

The integration of such technologies into clinical practice allows for a more streamlined and effective approach to MSK care, benefiting all parties involved in the workers' compensation process.

Precision as a Financial and Clinical Necessity

In MSK care, precision is essential not only for optimal patient outcomes but also for cost management. Accurate data and standardized assessments enable healthcare providers to identify the true drivers of MSK costs, allowing for targeted interventions that reduce expenses. This approach leads to faster recovery times, fewer repeat claims, and a more efficient return-to-work process for injured workers.

Real-World Impact: Faster Recovery and Improved Outcomes

The "digitally-enabled" physical therapist is emerging as a cornerstone of this new MSK care paradigm. By leveraging digital assessment tools, these professionals can offer a more precise and objective assessment, leading to personalized treatment plans and measurable improvements in recovery times. 

The unified language across the care team ensures that everyone, from therapists to surgeons, is working towards a common goal—enhancing the patient experience and expediting recovery.

Shaping the Future of Musculoskeletal Health

The panel discussion "Creating a Common Language in Musculoskeletal Care" at the NWCD event provided a glimpse into the future of MSK care. 

By adopting technology-driven approaches and fostering collaboration across the MSK care continuum, healthcare providers can ensure that injured workers receive the most effective and efficient care possible. This approach not only benefits patients but also has a significant impact on workers' compensation stakeholders, helping to drive down claims costs and promote healthier, more resilient workforces.

Blog

We think big and we think as a collective.